In brief
Health authorities in Nigeria confirmed the diagnosis of Ebola in a female patient who travelled from Uganda to Abuja in early October. The isolated patient was not a citizen but the wife of a diplomat, and contact tracing identified 44 close contacts. This marks the first West African state to report a case linked to the ongoing East African outbreak, which began in May. The Nigerian Centre for Disease Control has stepped up surveillance, advising travellers and emphasizing rapid medical attention for symptoms.
Health Minister Muhammad Ali Pate confirmed that the diagnosis of Ebola was verified by laboratory tests, after a female patient arrived from Uganda in late‑September. The 39‑year‑old, who is not a Nigerian citizen but the wife of a diplomat, was taken to a hospital in Abuja and placed in strict isolation.
The patient began showing symptoms four days after arrival, on 7 October, indicating an incubation period on the shorter end of the disease’s 2‑to‑21‑day window. Contact‑tracing teams have identified 44 close contacts who are being monitored for signs of infection.
Nigeria, which successfully contained an Ebola outbreak in 2014 that claimed eight deaths, is now the first West African country to register a case linked to the current outbreak that started in the Democratic Republic of Congo. Uganda, the patient’s last transit point, has declared itself free of the virus after its final case was discharged in August.
The Nigeria Centre for Disease Control has intensified disease surveillance and issued guidance to travellers, urging those arriving from countries with ongoing Ebola transmission to fill out health declaration forms and seek medical care promptly if symptoms arise. While travellers from other regions remain exempt, the public is asked to cooperate fully with contact‑tracing efforts.
The virus has also recently spread to Kenya, where nine cases have been confirmed; the United States has advised citizens to review travel plans to that country. With the new case, the West African region faces a heightened risk of cross‑border transmission, prompting robust public health responses.
